Cornerstone Planning Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.25K Hold
170
﹤0.01% 1129
2026
Q1
$4.2K Hold
170
﹤0.01% 1130
2025
Q4
$2.19K Hold
170
﹤0.01% 1175
2025
Q3
$1.89K Buy
170
+155
+1,033% +$1.81K ﹤0.01% 1170
2025
Q2
$148 Hold
15
﹤0.01% 1474
2025
Q1
$186 Hold
15
﹤0.01% 1468
2024
Q4
$254 Sell
15
-57
-79% -$1.13K ﹤0.01% 1309
2024
Q3
$1.63K Hold
72
﹤0.01% 824
2024
Q2
$1.65K Buy
72
+57
+380% +$1.11K ﹤0.01% 822
2024
Q1
$296 Hold
15
﹤0.01% 993
2023
Q4
$336 Hold
15
﹤0.01% 817
2023
Q3
$303 Hold
15
﹤0.01% 972
2023
Q2
$383 Buy
+15
New +$395 ﹤0.01% 1480
2022
Q4
$432 Buy
+15
New +$367 ﹤0.01% 1470

Other funds holding AVNS

Cornerstone Planning Group's AVNS Position: Q2 2026 in Review

Cornerstone Planning Group held its Avanos Medical (AVNS) position steady in Q2 2026 at 170 shares worth $4.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

Cornerstone Planning Group first reported a position in AVNS in Q4 2022 and has held it in 14 quarters since. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Cornerstone Planning Group held 170 shares of Avanos Medical worth $4.25K as of Q2 2026.
  • Cornerstone Planning Group left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1129 holding.
  • Cornerstone Planning Group first reported a position in Avanos Medical in Q4 2022 and has held it in 14 quarters since.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.